LeMaitre Vascular Net Profit Margin 2010-2025 | LMAT
LeMaitre Vascular net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| LeMaitre Vascular Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.23B | $0.05B | 19.82% |
| 2024-12-31 | $0.22B | $0.04B | 20.00% |
| 2024-09-30 | $0.21B | $0.04B | 19.25% |
| 2024-06-30 | $0.21B | $0.04B | 18.54% |
| 2024-03-31 | $0.20B | $0.03B | 17.09% |
| 2023-12-31 | $0.19B | $0.03B | 15.54% |
| 2023-09-30 | $0.19B | $0.03B | 15.14% |
| 2023-06-30 | $0.18B | $0.03B | 14.12% |
| 2023-03-31 | $0.17B | $0.02B | 12.43% |
| 2022-12-31 | $0.16B | $0.02B | 12.96% |
| 2022-09-30 | $0.16B | $0.02B | 13.04% |
| 2022-06-30 | $0.16B | $0.02B | 14.38% |
| 2022-03-31 | $0.16B | $0.03B | 16.98% |
| 2021-12-31 | $0.16B | $0.03B | 17.42% |
| 2021-09-30 | $0.15B | $0.03B | 18.30% |
| 2021-06-30 | $0.15B | $0.03B | 19.21% |
| 2021-03-31 | $0.14B | $0.03B | 18.52% |
| 2020-12-31 | $0.13B | $0.02B | 16.92% |
| 2020-09-30 | $0.12B | $0.02B | 16.39% |
| 2020-06-30 | $0.12B | $0.02B | 14.78% |
| 2020-03-31 | $0.12B | $0.02B | 15.13% |
| 2019-12-31 | $0.12B | $0.02B | 16.38% |
| 2019-09-30 | $0.11B | $0.02B | 17.54% |
| 2019-06-30 | $0.11B | $0.02B | 17.43% |
| 2019-03-31 | $0.11B | $0.02B | 21.50% |
| 2018-12-31 | $0.11B | $0.02B | 21.90% |
| 2018-09-30 | $0.10B | $0.02B | 20.39% |
| 2018-06-30 | $0.10B | $0.02B | 21.15% |
| 2018-03-31 | $0.10B | $0.02B | 17.48% |
| 2017-12-31 | $0.10B | $0.02B | 16.83% |
| 2017-09-30 | $0.10B | $0.02B | 16.33% |
| 2017-06-30 | $0.10B | $0.01B | 14.58% |
| 2017-03-31 | $0.09B | $0.01B | 13.04% |
| 2016-12-31 | $0.09B | $0.01B | 12.50% |
| 2016-09-30 | $0.09B | $0.01B | 12.94% |
| 2016-06-30 | $0.08B | $0.01B | 12.35% |
| 2016-03-31 | $0.08B | $0.01B | 11.39% |
| 2015-12-31 | $0.08B | $0.01B | 10.26% |
| 2015-09-30 | $0.08B | $0.01B | 9.09% |
| 2015-06-30 | $0.08B | $0.01B | 7.89% |
| 2015-03-31 | $0.07B | $0.01B | 6.76% |
| 2014-12-31 | $0.07B | $0.00B | 5.56% |
| 2014-09-30 | $0.07B | $0.00B | 4.23% |
| 2014-06-30 | $0.07B | $0.00B | 4.41% |
| 2014-03-31 | $0.07B | $0.00B | 4.55% |
| 2013-12-31 | $0.06B | $0.00B | 6.25% |
| 2013-09-30 | $0.06B | $0.00B | 6.56% |
| 2013-06-30 | $0.06B | $0.00B | 6.67% |
| 2013-03-31 | $0.06B | $0.00B | 6.90% |
| 2012-12-31 | $0.06B | $0.00B | 5.26% |
| 2012-09-30 | $0.06B | $0.00B | 3.64% |
| 2012-06-30 | $0.06B | $0.00B | 3.57% |
| 2012-03-31 | $0.06B | $0.00B | 3.51% |
| 2011-12-31 | $0.06B | $0.00B | 3.45% |
| 2011-09-30 | $0.06B | $0.00B | 6.78% |
| 2011-06-30 | $0.06B | $0.01B | 8.62% |
| 2011-03-31 | $0.06B | $0.01B | 10.53% |
| 2010-12-31 | $0.06B | $0.01B | 12.50% |
| 2010-09-30 | $0.06B | $0.01B | 10.71% |
| 2010-06-30 | $0.06B | $0.01B | 9.09% |
| 2010-03-31 | $0.05B | $0.00B | 7.41% |
| 2009-12-31 | $0.05B | $0.00B | 1.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.863B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |